Human Hematopoietic‐Myeloid Leukemia Cell Line (AML14.3D10)

Cat. No.
T8172
Unit
1x106 cells / 1.0 ml
Price
$570.00

Worried about losing your cells due to growth or thawing difficulties, or even a random freezer breakdown? Enjoy peace of mind knowing that you can be covered under abm's Cell Line Insurance.

Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing institution.

For for-profit organizations, please contact quotes@abmgood.com for pricing.

Cat. No. T8172
Name Human Hematopoietic‐Myeloid Leukemia Cell Line (AML14.3D10)
Description

 

The AML14.3D10 cell line is the fully differentiated eosinophilic subline of the AML14 (Cat. T8171) cell line. These cells maintain an eosinophilic phenotype and proliferate without the addition of exogenous cytokines. AML14.3D10 proliferates rapidly in response to GM-CSF and IL-5 and expresses the α‐subunit of the IL‐3 receptor.

Organism Human (H. sapiens)
Tissue Peripheral Blood
Donor History Male, 68, FAB M2 Acute Myeloid Leukemia
Growth Properties

Suspension, round. Proliferates as an eosinophilic myelocyte to met amyelocyte, containing eosinophil secondary granules

Unit 1x106 cells / 1.0 ml
Storage Condition Vapor phase of liquid nitrogen, or below -130°C.
Shipping Conditions

Ship with dry ice.

Product Format Frozen
Intended Use This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
BioSafety II
Certificate of Analysis For batch-specific test results, refer to the applicable certificate of analysis that can be found at www.abmgood.com.
Growth Conditions

PriCoat™ T25 Flasks (G299) are recommended for optimal cell culture. PriGrow II (TM002) + 8% FBS + 2mM L-glutamine (G275) + 1mM Sodium Pyruvate (TM057) + 50uM Beta- mercaptoethanol + 1% Penicillin/Streptomycin Solution (G255), 37.0°C, 5% CO₂. 

Note: Cells are difficult to recover from freeze-thaw conditions and typically show 20-30% viability post-thaw; allow cells to recover in the first 72 hours through frequent media changes. It is absolutely imperative to perform a cell viabilty count each time cells are passaged  to keep them between 3 x 105 – 1 x 106 maximum/ml. Do not allow the cells to achieve a density greater than 8 X 105 viable cells/ml.; this will lead to terminal differentiation and cell death. 

Addition of 100 pg/ml GM-CSF to the culture media during the first week post-thaw will allow for more rapid recovery and improved cell viability. 

Unpacking and Storage Instructions

1. Visually examine the packaging containers for signs of leakage or breakage.

2. Immediately transfer frozen cells from dry ice packaging to a temperature below -130°C, preferably in liquid nitrogen vapor phase storage, until ready for use.

To ensure the highest level of viability, thaw the vial and initiate culture as soon as possible upon receipt. If continued storage is desired, the vial should only be stored below -130°C or in liquid nitrogen vapor phase. Do not store at -70°C, as it will result in loss of viability.

Thawing Protocol

 

1. Thaw cells quickly in a 37°C water bath while agitating gently (maximum 2 minutes). The vial cap should be kept above the water level to minimize the risk of contamination.

2. Decontaminate the vial by spraying and wiping the exterior of the vial with 70% ethanol. From this point onwards, all operations should be strictly carried out inside a biological safety cabinet using aseptic conditions.

3. Transfer the cell suspension into a 15ml sterile conical tube containing 5ml of pre-warmed, complete growth media. Centrifuge cells at 1000 rpm for 10 minutes in a swinging bucket rotor.

4. Aspirate the supernatant without disturbing the cell pellet. Re-suspend the cell pellet in 10 ml of the recommended pre-warmed, complete growth media and dispense into a T25 culture flask.

5. Incubate the cells for 5 hours, with the flask standing upright at the recommended conditions.

6. Transfer 5ml of these cells into a second flask containing 5ml of complete media.Add 5ml of fresh media to the original flask.

7. Incubate both flasks for 3-5 days (the cell concentration should be greater than 3.5

x 105 cells/ml) before passing in fresh media.

8. Allow cells to grow to 8 x105/ml (but not higher!!!) with a viability of greater

than 90%.

9. Continue passing the cells on the regular 3-4 day schedule. Do not allow the cells to achieve a density greater than 8 X 105 viable cells/ml.

Subculture Protocol

Cells must be maintained 3 x 105 – 1 x 106 maximum/ml. Perform a cell viabiity count each time cells are passaged.

  1. Do not spin down and wash cells to passage them unless exogenous GM-CSF will be added to the culture. 

  2. Dilute cells by adding fresh media and spitting to new culture ware for a final concentration of 3 - 3.5 x 105 cells/ml.

Cryopreservation

We recommend using serum-free CryoGuard™  Freezing Media (TM078) or, if serum is preferred, Cryopreservation Medium (TM024).

Seeding Density (cells/ml) 30,000 - 35,000 (every 3-4 days) DO NOT ALLOW CELLS TO EXCEED 1 x 10^6 CELLS/ML
STR Profiling

D5S818 : 10,11

D13S317 : 12,12

D7S820 : 10,14

D16S539 : 9,12

VWA : 18,19

TH01 : 9,9.3

AMEL : X,Y

TPOX : 9,11

CSF1PO : 13,13

D12S391 : 18,19

FGA : 20,22

D2S1338 : 19,22

D21S11 : 30,30

D18S51 : 15,15

D8S1179 : 14,14

D3S1358 : 15,19

D6S1043 : 11,17

PENTAE : 7,7

D19S433 : 12,14

PENTAD : 11,11

D1S1656 : 12,13

Warranty abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period”.
Disclaimer

1. Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at licensing@abmgood.com.

2. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 μg, Cat.# C207, $450.00) or cell lysate (100 μg, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final.

3. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping).

4. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information.

5. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate.

6. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period."

Depositor Wright State University
Application

Research Use Only.

Material Citation If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. T8172
Print/Download Datasheet
  • Paul, C. C., Ackerman, S. J., Mahrer, S., Tolbert, M., Dvorak, A. M., & Baumann, M. A. (1994). Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14. Journal of Leucocyte Biology, 56(1), 74-79.


    Paul, C. C., Mahrer, S., Tolbert, M., Elbert, B. L., Wong, I., Ackerman, S. J., & Baumann, M. A. (1995). Changing the differentiation program of hematopoietic cells: retinoic acid-induced shift of eosinophil-committed cells to neutrophils.


    Baumann, M. A., & Paul, C. C. (1998). The AML14 and AML14. 3D10 cell lines: a long-overdue model for the study of eosinophils and more. Stem Cells, 16(1), 16-24

This product has no review yet.